| Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies JT Griffin, TD Hollingsworth, LC Okell, TS Churcher, M White, W Hinsley, ... PLoS medicine 7 (8), e1000324, 2010 | 672 | 2010 |
| Immunogenicity of the RTS, S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial MT White, R Verity, JT Griffin, KP Asante, S Owusu-Agyei, B Greenwood, ... The Lancet infectious diseases 15 (12), 1450-1458, 2015 | 397 | 2015 |
| Costs and cost-effectiveness of malaria control interventions-a systematic review MT White, L Conteh, R Cibulskis, AC Ghani Malaria journal 10, 1-14, 2011 | 338 | 2011 |
| Strategies for Understanding and Reducing the Plasmodium vivax and Plasmodium ovale Hypnozoite Reservoir in Papua New Guinean Children: A Randomised … LJ Robinson, R Wampfler, I Betuela, S Karl, MT White, CSN Li Wai Suen, ... PLoS medicine 12 (10), e1001891, 2015 | 278 | 2015 |
| Modelling the impact of vector control interventions on Anopheles gambiae population dynamics MT White, JT Griffin, TS Churcher, NM Ferguson, MG Basáñez, AC Ghani Parasites & vectors 4, 1-14, 2011 | 262 | 2011 |
| Public health impact and cost-effectiveness of the RTS, S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models MA Penny, R Verity, CA Bever, C Sauboin, K Galactionova, S Flasche, ... The Lancet 387 (10016), 367-375, 2016 | 244 | 2016 |
| The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection MT White, P Bejon, A Olotu, JT Griffin, EM Riley, KE Kester, ... PloS one 8 (4), e61395, 2013 | 221 | 2013 |
| Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis PGT Walker, MT White, JT Griffin, A Reynolds, NM Ferguson, AC Ghani The Lancet Infectious Diseases 15 (7), 825-832, 2015 | 218 | 2015 |
| The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria LC Okell, JT Griffin, I Kleinschmidt, TD Hollingsworth, TS Churcher, ... PLOS one 6 (5), e20179, 2011 | 164 | 2011 |
| Dynamics of the Antibody Response to Plasmodium falciparum Infection in African Children MT White, JT Griffin, O Akpogheneta, DJ Conway, KA Koram, EM Riley, ... The Journal of infectious diseases 210 (7), 1115-1122, 2014 | 161 | 2014 |
| Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination AM Minassian, SE Silk, JR Barrett, CM Nielsen, K Miura, A Diouf, C Loos, ... Med 2 (6), 701-719. e19, 2021 | 134 | 2021 |
| Efficacy of RTS, S malaria vaccines: individual-participant pooled analysis of phase 2 data P Bejon, MT White, A Olotu, K Bojang, JPA Lusingu, N Salim, NN Otsyula, ... The Lancet infectious diseases 13 (4), 319-327, 2013 | 127 | 2013 |
| Development and validation of serological markers for detecting recent Plasmodium vivax infection RJ Longley, MT White, E Takashima, J Brewster, M Morita, M Harbers, ... Nature medicine 26 (5), 741-749, 2020 | 123 | 2020 |
| Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission MT White, S Karl, KE Battle, SI Hay, I Mueller, AC Ghani Elife 3, e04692, 2014 | 118 | 2014 |
| Eliminating malaria vectors GF Killeen, A Seyoum, C Sikaala, AS Zomboko, JE Gimnig, NJ Govella, ... Parasites & vectors 6, 1-10, 2013 | 118 | 2013 |
| The early transmission dynamics of H1N1pdm influenza in the United Kingdom A Ghani, M Baguelin, J Griffin, S Flasche, AJ Van Hoek, S Cauchemez, ... PLoS currents 1, RRN1130, 2010 | 115 | 2010 |
| Targets of complement-fixing antibodies in protective immunity against malaria in children L Reiling, MJ Boyle, MT White, DW Wilson, G Feng, R Weaver, DH Opi, ... Nature communications 10 (1), 610, 2019 | 107 | 2019 |
| Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study J Rosado, S Pelleau, C Cockram, SH Merkling, N Nekkab, C Demeret, ... The Lancet Microbe 2 (2), e60-e69, 2021 | 104 | 2021 |
| A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS, S malaria vaccine MT White, P Bejon, A Olotu, JT Griffin, K Bojang, J Lusingu, N Salim, ... BMC medicine 12, 1-11, 2014 | 104 | 2014 |
| Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies J Dufloo, L Grzelak, I Staropoli, Y Madec, L Tondeur, F Anna, S Pelleau, ... Cell Reports Medicine 2 (5), 2021 | 91 | 2021 |
